There were fewer patients with extrahepatic metastases in group A versus group B ( group A , 6 cases or 9.84 % [ 95 % CI , 2.36 % -17.31 % ] ; group B , 12 cases or 18.75 % [ 95 % CI , 9.19 % -28.31 % ] ) .